Kone's $34 Billion Acquisition of TK Elevator Is a Masterclass in Stock-and-Cash M&A

On April 29, 2026, Finland's Kone Oyj agreed to acquire TK Elevator from Advent International and Cinven in a transaction valued at 29.4 billion euros, or roughly $34.4 billion including assumed net debt. The combination will create the world's largest elevator and escalator manufacturer, with about 20.5 billion euros in pro forma annual revenue and more than 100,000 employees across 100 countries. For business owners watching the M&A tape, this deal is more than a European headline. It is a working example of how strategic buyers build a winning bid when share currency, debt assumption, and synergy capture all line up.

What's Actually Inside the Deal

The headline of $34.4 billion includes about 9.2 billion euros of refinanced TK Elevator debt. The equity check breaks into two pieces: 5 billion euros in cash and up to 270 million new Kone class B shares, valued at approximately 15.2 billion euros based on Kone's April 28 share price. The rest comes from existing TK Elevator debt that Kone will refinance at close.

Two structural features stand out. First, sellers Advent and Cinven (along with their co-investors) will hold a meaningful stake in the combined entity through the share consideration, which means they remain exposed to integration outcomes. Second, the cash portion is small relative to deal size, which keeps Kone's pro forma leverage in a range it can defend with rating agencies. This is the kind of structure a public strategic can build that a sponsor cannot match.

Kone has guided to roughly 700 million euros in annual run-rate synergies once the integration matures. At Kone's current trading multiple, that synergy stream alone supports several billion euros of value before any revenue lift or modernization economics. That cushion is what turns a competitive bid into a winning one.

Why Stock Consideration Often Beats All Cash

Sellers love cash. Cash removes price risk, buyer risk, and timing risk. Yet here, two of the most disciplined sponsors in the market accepted the majority of their consideration in stock. The reason is straightforward: in a strategic combination with credible synergies, the value of the buyer's shares post-close should reflect the synergy math, and a large enough roll lets the seller capture upside they would otherwise leave on the table.

This logic applies far below blue-chip strategics. A founder selling to a regional roll-up sponsor, a family business merging with a complementary competitor, or a software company being absorbed into a larger platform should all evaluate stock consideration on the same framework: what is the buyer's currency worth, how reliable are the synergies, and what is the lockup and liquidity profile of the shares received.

The Antitrust and Closing Calendar Risk

Kone has flagged that closing cannot occur before the second quarter of 2027. That is a long road. The combined company will hold a leading position in elevator and escalator manufacturing across Europe, North America, and parts of Asia, which guarantees serious antitrust review in the European Union, the United States, China, and likely a half-dozen other jurisdictions. Rival Schindler has already signaled it will object.

For sellers, a 12 to 15 month gap between signing and closing creates real exposure: continued capital investment, key employee retention, customer churn, and macro risk all sit on the seller's side until the deal closes. Sophisticated sellers price this. Reverse termination fees, divestiture commitments, hell-or-high-water clauses, and regulatory cooperation obligations should all be negotiated at signing. Boards reviewing strategic offers should ask their advisors to lay out the regulatory pathway with the same rigor they apply to valuation.

Refinancing Existing Debt as a Hidden Lever

The 9.2 billion euros of TK Elevator debt being refinanced is more than a footnote. Sponsors who took the company private in 2020 levered it during a high-yield-friendly window. Refinancing that stack at Kone's investment-grade cost of capital is itself a synergy. It also clears a path for Kone to recap the combined company toward its target capital structure.

For owners of leveraged businesses, this is a useful framing. A buyer that can refinance your debt at a lower cost of capital is paying not just for your business, but for the value of cheaper capital. That spread should be reflected in the price. Sellers running a process should make sure the bid evaluation captures financing assumptions, not just enterprise value.

What This Says About 2026 Cross-Border M&A

This is the second large cross-border industrial transaction announced in the past two weeks, following Apollo's $2.1 billion carve-out of Forvia's auto interiors business. Combined with Sun Pharma's $11.75 billion all-cash bid for Organon, the pattern is clear: large strategic buyers and sponsors are deploying serious capital into transformative deals where the synergy math is durable and the financing windows are open.

A few characteristics of the 2026 environment make these deals possible. Investment-grade strategics with strong stock currency can stretch on price using share consideration without straining credit ratings. Holdings from the 2018 to 2021 vintage years are aging and need exits, supplying a steady flow of high-quality sponsor-owned assets. Boards have learned that disciplined integration playbooks deliver, so synergy ranges are wider than they were five years ago. And cross-border antitrust, while harder, is treatable through divestitures and behavioral remedies for well-prepared buyers.

What to Watch Next

Three threads will play out over the next several quarters. First, whether Schindler's antitrust intervention forces meaningful divestitures, which would set a template for industrial consolidation more broadly. Second, whether Kone's stock holds the value implied at signing, which determines what the deal actually delivers to Advent and Cinven. Third, whether the synergy guidance proves conservative or aggressive once integration begins; this will inform how the market prices similar combinations in the second half of 2026.